John Couling Sells 7,667 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $53.20, for a total transaction of $407,884.40. Following the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $6,316,276.40. The trade was a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Dolby Laboratories Trading Down 1.5%

Shares of NYSE:DLB opened at $49.30 on Wednesday. The stock has a market capitalization of $4.66 billion, a P/E ratio of 19.49 and a beta of 0.81. The stock’s 50-day moving average price is $54.73 and its 200-day moving average price is $60.37. Dolby Laboratories has a 12-month low of $48.66 and a 12-month high of $77.00.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the previous year, the company posted $1.34 EPS. Dolby Laboratories’s revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, research analysts predict that Dolby Laboratories will post 3.21 EPS for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were issued a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.9%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.

Institutional Trading of Dolby Laboratories

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. State Street Corp increased its position in Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after purchasing an additional 180,072 shares during the period. First Trust Advisors LP lifted its position in shares of Dolby Laboratories by 19.9% in the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after purchasing an additional 374,405 shares during the period. Geode Capital Management LLC boosted its stake in shares of Dolby Laboratories by 15.6% during the 4th quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after purchasing an additional 254,250 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after buying an additional 592,282 shares during the period. Finally, Snyder Capital Management L P raised its stake in Dolby Laboratories by 24.4% in the fourth quarter. Snyder Capital Management L P now owns 1,427,093 shares of the electronics maker’s stock worth $91,648,000 after buying an additional 279,743 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on DLB shares. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research report on Thursday, June 11th. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.